plerixafor has been researched along with Plasma Cell Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansell, SM; Buadi, F; Dingli, D; Dispenzieri, A; Gastineau, DA; Gertz, MA; Hayman, SR; Hogan, WJ; Inwards, DJ; Johnston, PB; Kumar, S; Lacy, MQ; Litzow, MR; Micallef, IN; Porrata, LF; Sinha, S; Winters, JL; Wolf, R | 1 |
1 trial(s) available for plerixafor and Plasma Cell Tumor
Article | Year |
---|---|
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.
Topics: Adult; Aged; Algorithms; Benzylamines; Case-Control Studies; Costs and Cost Analysis; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasmacytoma; Risk Factors; Time Factors; Transplantation, Autologous | 2013 |